Issue 3, 2015

A europium–lipoprotein nanocomposite for highly-sensitive MR-fluorescence multimodal imaging

Abstract

A novel reconstituted high-density lipoprotein (rHDL) nanocomposite has been prepared for highly-sensitive magnetic resonance (MR)-fluorescence multimodal imaging. Such a nanocomposite is able to enhance the MR sensitivity up to 129 fold in comparison to the traditional small molecule MRI agent based on paramagnetic chemical exchange saturation transfer (PARACEST). It has also demonstrated specific targeting to macrophage cells, which shows great potential for the detection of atherosclerosis.

Graphical abstract: A europium–lipoprotein nanocomposite for highly-sensitive MR-fluorescence multimodal imaging

Supplementary files

Article information

Article type
Communication
Submitted
11 Oct 2014
Accepted
28 Nov 2014
First published
28 Nov 2014

RSC Adv., 2015,5, 1808-1811

Author version available

A europium–lipoprotein nanocomposite for highly-sensitive MR-fluorescence multimodal imaging

Q. Wang, S. Chen, Q. Luo, M. Liu and X. Zhou, RSC Adv., 2015, 5, 1808 DOI: 10.1039/C4RA12201A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements